Thrombectomy Systems (Catheters) Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Thrombectomy Systems (Catheters) Pipeline Market Report Overview

Thrombectomy system involves the application of negative pressure for the removal of thrombi which is sometimes accompanied with thrombolytic drugs.  The procedure is automated with the help of a console (or control unit) to which the catheter is attached. The Thrombectomy Systems (Catheters) pipeline market research report provides comprehensive information about the Thrombectomy Systems (Catheters) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Thrombectomy Systems (Catheters) Pipeline Market Segmentation by Territories

Some of the key territories in the Thrombectomy Systems (Catheters)pipeline market are the US, China, Japan, Mexico, Brazil, Europe, and France. In 2023, the US has the highest number of pipeline products.

Thrombectomy Systems (Catheters) Pipeline Market Analysis, by Territories, 2023 (%)

Thrombectomy Systems (Catheters) Pipeline Market Analysis, by Territories, 2023 (%)

For more territory insights into the Thrombectomy Systems (Catheters) pipeline market, download a free report sample

Thrombectomy Systems (Catheters) Pipeline Market Segmentation by Regulatory Paths

The key regulatory paths in the Thrombectomy Systems (Catheters) pipeline market are 510(k), NMPA, Ninsho, ANVISA, CE, PMA, and Shonin. In 2023, 510(k) was the most followed pathway for pipeline products.

Thrombectomy Systems (Catheters)Pipeline Market Analysis, by Regulatory Paths, 2023 (%)

Thoracic Aortic Stent Grafts Pipeline Market Analysis, by Regulatory Paths, 2023 (%)

For more regulatory paths into the Thrombectomy Systems (Catheters) pipeline market, download a free report sample

Thrombectomy Systems (Catheters) Pipeline Market- Competitive Landscape

Some of the key companies in the Thrombectomy Systems (Catheters) pipeline market are AngioDynamics Inc, Boston Scientific Corp, Caeli Vascular LLC, Capture Vascular Inc, Inari Medical Inc, Innova Vascular Inc, Jiangsu Zhenyi Medical Technology Co Ltd, Liquet Medical Inc, Merit Medical Systems Inc, and MicroPort Scientific Corp.

Boston Scientific Corp: Headquartered in Marlborough, Massachusetts, the US, Boston Scientific Corp (Boston Scientific) is a medical technology company that is involved in the development, manufacturing and commercialization of devices for a range of interventional medical specialties. The company offers products in the areas of electrophysiology, gastroenterology, gastrointestinal surgery, female pelvic medicine, gynecology, interventional cardiology, interventional radiology, neurological surgery, orthopedic surgery, pain medicine, pulmonology, urology and vascular surgery.

Capture Vascular Inc: Headquartered in Mesa, Arizona, the US, Capture Vascular Inc (Capture Vascular) is a medical device development company that develops and commercializes mechanical thrombectomy systems. The company offers MegaVac, a mechanical thrombectomy system that removes clots in arteries and provides vessel occlusion, embolic prevention and anchoring capabilities. Its mechanical thrombectomy system is also designed to remove thrombus and emboli throughout the peripheral and coronary vasculature by occluding, disrupting and removing embolic and thrombotic materials.

Inari Medical Inc: Headquartered in Irvine, California, the US, Inari Medical Inc (Inari), formerly Inceptus Newco1 Inc, is a medical device company focused on developing products to treat venous diseases. The Company’s product offering consists of two minimally invasive, catheter-based mechanical thrombectomy devices. It offers solutions that enable the safe removal of clot volumes from big vessels.

Thrombectomy Systems (Catheters) Pipeline Market Report Overview

Key Territories The US, China, Japan, Mexico, Brazil, Europe, and France
Key Regulatory Paths 510(k), NMPA, Ninsho, ANVISA, CE, PMA, and Shonin
Leading Companies AngioDynamics Inc, Boston Scientific Corp, Caeli Vascular LLC, Capture Vascular Inc, Inari Medical Inc, Innova Vascular Inc, Jiangsu Zhenyi Medical Technology Co Ltd, Liquet Medical Inc, Merit Medical Systems Inc, and MicroPort Scientific Corp

Segments Covered in the Report

Thrombectomy Systems (Catheters) Pipeline Market Territories Outlook

  • The US
  • China
  • Japan
  • Mexico
  • Brazil
  • Europe
  • France

Thrombectomy Systems (Catheters) Pipeline Market Regulatory Paths Outlook

  • 510(k)
  • NMPA
  • Ninsho
  • ANVISA
  • CE
  • PMA
  • Shonin

Scope

  • Extensive coverage of the Thrombectomy Systems (Catheters) under development.
  • Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths, and estimated approval dates.
  • Reviews of major players involved in the pipeline product development.
  • Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and the number of trials of the major Thrombectomy Systems (Catheters) pipeline products.
  • Review of Recent Developments in the segment / industry.

Reasons to Buy

The Thrombectomy Systems (Catheters) report enables you to:

  • Access significant competitor information, analysis, and insights to improve your R&D strategies.
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage.
  • Identify and understand important and diverse types of Thrombectomy Systems (Catheters) under development.
  • Formulate market-entry and market expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.

AngioDynamics Inc
Boston Scientific Corp
Caeli Vascular LLC
Capture Vascular Inc
Inari Medical Inc
Innova Vascular Inc
Jiangsu Zhenyi Medical Technology Co Ltd
Liquet Medical Inc
Merit Medical Systems Inc
MicroPort Scientific Corp
Morningside (Nantong) Medical Co Ltd
NexGen Medical Systems Inc
OrbusNeich
Penumbra Inc
Shanghai Changde Medical Technology Co Ltd
Shanghai MicroPort Endovascular MedTech Co Ltd
Suzhou Tianhong Shengjie Medical Co Ltd
TransMed7 LLC
University of California Los Angeles
University of Toledo
University of Wolverhampton
Wallaby Medical Inc
WaveClear Inc
Zylox-Tonbridge Medical Technology Co Ltd

Table of Contents

  • 1 Table of Contents

    • 1.1 List of Tables
    • 1.2 List of Figures

  • 2 Introduction

    • 2.1 Thrombectomy Systems (Catheters) Overview

  • 3 Products under Development

    • 3.1 Thrombectomy Systems (Catheters) – Pipeline Products by Stage of Development
    • 3.2 Thrombectomy Systems (Catheters) – Pipeline Products by Territory
    • 3.3 Thrombectomy Systems (Catheters) – Pipeline Products by Regulatory Path
    • 3.4 Thrombectomy Systems (Catheters) – Pipeline Products by Estimated Approval Date
    • 3.5 Thrombectomy Systems (Catheters) – Ongoing Clinical Trials

  • 4 Thrombectomy Systems (Catheters) – Pipeline Products under Development by Companies

    • 4.1 Thrombectomy Systems (Catheters) Companies – Pipeline Products by Stage of Development
    • 4.2 Thrombectomy Systems (Catheters) – Pipeline Products by Stage of Development

  • 5 Thrombectomy Systems (Catheters) Companies and Product Overview

    • 5.1 AngioDynamics Inc Company Overview

      • 5.1.1 AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.2 Boston Scientific Corp Company Overview

      • 5.2.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview

    • 5.3 Caeli Vascular LLC Company Overview

      • 5.3.1 Caeli Vascular LLC Pipeline Products & Ongoing Clinical Trials Overview

    • 5.4 Capture Vascular Inc Company Overview

      • 5.4.1 Capture Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.5 Inari Medical Inc Company Overview

      • 5.5.1 Inari Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.6 Innova Vascular Inc Company Overview

      • 5.6.1 Innova Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.7 Jiangsu Zhenyi Medical Technology Co Ltd Company Overview

      • 5.7.1 Jiangsu Zhenyi Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.8 Liquet Medical Inc Company Overview

      • 5.8.1 Liquet Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.9 Merit Medical Systems Inc Company Overview

      • 5.9.1 Merit Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.10 MicroPort Scientific Corp Company Overview

      • 5.10.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview

    • 5.11 Morningside (Nantong) Medical Co Ltd Company Overview

      • 5.11.1 Morningside (Nantong) Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.12 NexGen Medical Systems Inc Company Overview

      • 5.12.1 NexGen Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.13 OrbusNeich Company Overview

      • 5.13.1 OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview

    • 5.14 Penumbra Inc Company Overview

      • 5.14.1 Penumbra Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.15 Shanghai Changde Medical Technology Co Ltd Company Overview

      • 5.15.1 Shanghai Changde Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.16 Shanghai MicroPort Endovascular MedTech Co Ltd Company Overview

      • 5.16.1 Shanghai MicroPort Endovascular MedTech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.17 Suzhou Tianhong Shengjie Medical Co Ltd Company Overview

      • 5.17.1 Suzhou Tianhong Shengjie Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.18 TransMed7 LLC Company Overview

      • 5.18.1 TransMed7 LLC Pipeline Products & Ongoing Clinical Trials Overview

    • 5.19 University of California Los Angeles Company Overview

      • 5.19.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview

    • 5.20 University of Toledo Company Overview

      • 5.20.1 University of Toledo Pipeline Products & Ongoing Clinical Trials Overview

    • 5.21 University of Wolverhampton Company Overview

      • 5.21.1 University of Wolverhampton Pipeline Products & Ongoing Clinical Trials Overview

    • 5.22 Wallaby Medical Inc Company Overview

      • 5.22.1 Wallaby Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.23 WaveClear Inc Company Overview

      • 5.23.1 WaveClear Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.24 Zylox-Tonbridge Medical Technology Co Ltd Company Overview

      • 5.24.1 Zylox-Tonbridge Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

  • 6 Appendix

    • 6.1 Methodology
    • 6.2 About GlobalData
    • 6.3 Contact Us
    • 6.4 Disclaimer

Table

Thrombectomy Systems (Catheters) – Pipeline Products by Stage of Development 10

Thrombectomy Systems (Catheters) – Pipeline Products by Territory 11

Thrombectomy Systems (Catheters) – Pipeline Products by Regulatory Path 12

Thrombectomy Systems (Catheters) – Pipeline Products by Estimated Approval Date 13

Thrombectomy Systems (Catheters) – Ongoing Clinical Trials 14

Thrombectomy Systems (Catheters) Companies – Pipeline Products by Stage of Development 15

Thrombectomy Systems (Catheters) – Pipeline Products by Stage of Development 17

AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 19

AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 System – Product Status 19

AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 System – Product Description 20

Alphavac System – Infective Endocarditis – Product Status 20

Alphavac System – Infective Endocarditis – Product Description 20

Alphavac System – Left Atrial Appendage Thrombus – Product Status 21

Alphavac System – Left Atrial Appendage Thrombus – Product Description 21

AngioVac – Left Heart – Product Status 21

AngioVac – Left Heart – Product Description 22

Multi-Purpose Mechanical Aspiration – F1885 PE – Product Status 22

Multi-Purpose Mechanical Aspiration – F1885 PE – Product Description 22

Multi-Purpose Mechanical Aspiration Gen 2 – Product Status 23

Multi-Purpose Mechanical Aspiration Gen 2 – Product Description 23

AngioDynamics Inc – Ongoing Clinical Trials Overview 24

AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 System – Evaluating the Safety and Efficacy of the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE for Treatment of Acute Pulmonary Embolism 25

Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 26

AngioJet Clothunter – Product Status 26

AngioJet Clothunter – Product Description 26

Next Gen AngioJet – Product Status 27

Next Gen AngioJet – Product Description 27

Next Gen Ekos – Product Status 27

Next Gen Ekos – Product Description 27

Boston Scientific Corp – Ongoing Clinical Trials Overview 28

Next Gen AngioJet – Study on the Effect of Modified Angiojet Thrombectomy in Subjects with Lower Extremity Deep Venous Thrombosis 29

Caeli Vascular LLC Pipeline Products & Ongoing Clinical Trials Overview 30

Hydra Catheter Thrombectomy System – Product Status 30

Hydra Catheter Thrombectomy System – Product Description 30

Capture Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 31

DVT Device – Product Status 31

DVT Device – Product Description 31

Megavac – BTK – Product Status 32

Megavac – BTK – Product Description 32

Thrombowire Clot Retractor – BTK – Product Status 32

Thrombowire Clot Retractor – BTK – Product Description 33

Inari Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 34

3rd Gen ClotTriever – Product Status 34

3rd Gen ClotTriever – Product Description 35

ClotTriever Thrombectomy System – Product Status 35

ClotTriever Thrombectomy System – Product Description 35

FlowTriever Catheter – Product Status 36

FlowTriever Catheter – Product Description 36

FlowTriever2 Catheter – Product Status 36

FlowTriever2 Catheter – Product Description 37

FlowTriever2 Catheter – Pulmonary Embolism – Product Status 37

FlowTriever2 Catheter – Pulmonary Embolism – Product Description 37

Triever16 Curve – Product Status 38

Triever16 Curve – Product Description 38

Triever20 – Product Status 38

Triever20 – Product Description 39

Triever24 – Product Status 39

Triever24 – Product Description 39

Triever24 Flex Catheter – Product Status 40

Triever24 Flex Catheter – Product Description 40

Inari Medical Inc – Ongoing Clinical Trials Overview 41

ClotTriever Thrombectomy System – ClotTriever Outcomes (CLOUT) Registry 42

ClotTriever Thrombectomy System – DEFIANCE – ClotTriever Thrombectomy System vs. Anticoagulation Alone for Treatment of Deep Vein Thrombosis 42

Triever20 – FlowTriever All-comer Registry for Patient Safety and Hemodynamics: FLASH 43

Triever20 – The PEERLESS Study 43

FlowTriever Catheter – Treatment of Low-Risk Submassive Pulmonary Embolism With FlowTriever: Efficacy and Safety 44

FlowTriever2 Catheter – Pulmonary Embolism – FlowTriever Pulmonary Embolectomy Clinical Study – FlowTriever2 45

Innova Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 46

Deep Vein Thrombosis Device – Product Status 46

Deep Vein Thrombosis Device – Product Description 46

Mechanical Thrombectomy Device – Product Status 47

Mechanical Thrombectomy Device – Product Description 47

Jiangsu Zhenyi Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 48

Pulmonary Thrombectomy Device – Product Status 48

Pulmonary Thrombectomy Device – Product Description 48

Liquet Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 49

Versus Catheter – Product Status 49

Versus Catheter – Product Description 49

Merit Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 50

SPINR Macerator – Product Status 50

SPINR Macerator – Product Description 50

MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 51

Fishhawk Mechanical Thrombectomy Catheter – Product Status 51

Fishhawk Mechanical Thrombectomy Catheter – Product Description 51

Morningside (Nantong) Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 52

TwiFlow-Thrombectomy Catheter System – Product Status 52

TwiFlow-Thrombectomy Catheter System – Product Description 52

Morningside (Nantong) Medical Co Ltd – Ongoing Clinical Trials Overview 53

TwiFlow-Thrombectomy Catheter System – A Multicenter Prospective Single-arm Study to Evaluate the Safety and Efficacy of a Novel Transcatheter Pulmonary Thrombectomy System Which Named ‘TwiFlow’ for Acute Pulmonary Embolism 54

TwiFlow-Thrombectomy Catheter System – An Exploratory Study to Evaluate the Safety and Efficacy of a Novel Transcatheter Pulmonary Thrombectomy System which Named ‘TwiFlow’ for Acute Pulmonary Embolism 54

NexGen Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 55

XCOIL Shield – Product Status 55

XCOIL Shield – Product Description 55

OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview 56

Aspiration Catheter – Product Status 56

Aspiration Catheter – Product Description 56

Penumbra Inc Pipeline Products & Ongoing Clinical Trials Overview 57

Indigo Aspiration System – Lightning Aspiration Tubing – Product Status 57

Indigo Aspiration System – Lightning Aspiration Tubing – Product Description 58

Indigo Aspiration System – Separator 12 – Product Status 58

Indigo Aspiration System – Separator 12 – Product Description 58

Indigo System Aspiration Lightning 7 – Product Status 59

Indigo System Aspiration Lightning 7 – Product Description 59

Lightning Bolt – Product Status 59

Lightning Bolt – Product Description 60

Penumbra Inc – Ongoing Clinical Trials Overview 61

Indigo Aspiration System – Separator 12 – STORM-PE: A Prospective, Multicenter, Randomized Controlled Trial Evaluating Anticoagulation Alone vs Anticoagulation Plus Mechanical Aspiration With the Indigo Aspiration System for the Treatment of Intermediate High Risk Acute Pulmonary Embolism 62

Indigo Aspiration System – Lightning Aspiration Tubing – STORM-PE: A Prospective, Multicenter, Randomized Controlled Trial Evaluating Anticoagulation Alone vs Anticoagulation Plus Mechanical Aspiration With the Indigo Aspiration System for the Treatment of Intermediate High Risk Acute Pulmonary Embolism 63

Shanghai Changde Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 64

Cardiac Catheter – Deep Vein Thrombosis – Product Status 64

Cardiac Catheter – Deep Vein Thrombosis – Product Description 64

Shanghai MicroPort Endovascular MedTech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 65

Thrombectomy Catheter – Product Status 65

Thrombectomy Catheter – Product Description 65

Suzhou Tianhong Shengjie Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 66

Thrombolysis Catheter – Product Status 66

Thrombolysis Catheter – Product Description 66

Thrombus Removal Catheter – Product Status 67

Thrombus Removal Catheter – Product Description 67

TransMed7 LLC Pipeline Products & Ongoing Clinical Trials Overview 68

Hurricane – Product Status 68

Hurricane – Product Description 68

University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 69

Clot Retrieval System – Product Status 69

Clot Retrieval System – Product Description 69

University of Toledo Pipeline Products & Ongoing Clinical Trials Overview 70

Minimally Invasive Thrombectomy Device – Product Status 70

Minimally Invasive Thrombectomy Device – Product Description 70

University of Wolverhampton Pipeline Products & Ongoing Clinical Trials Overview 71

GP Mechanical Thrombectomy Device – Product Status 71

GP Mechanical Thrombectomy Device – Product Description 71

Wallaby Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 72

Esperance Aspiration Catheter System – Product Status 72

Esperance Aspiration Catheter System – Product Description 72

WaveClear Inc Pipeline Products & Ongoing Clinical Trials Overview 73

CaviClear Endovascular System – Product Status 73

CaviClear Endovascular System – Product Description 73

Zylox-Tonbridge Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 74

Peripheral Thrombectomy System – Product Status 74

Peripheral Thrombectomy System – Product Description 74

Glossary 77

Figures

Thrombectomy Systems (Catheters) – Pipeline Products by Stage of Development 10

Thrombectomy Systems (Catheters) – Pipeline Products by Territory 11

Thrombectomy Systems (Catheters) – Pipeline Products by Regulatory Path 12

Thrombectomy Systems (Catheters) – Pipeline Products by Estimated Approval Date 13

Thrombectomy Systems (Catheters) – Ongoing Clinical Trials 14

Frequently asked questions

Thrombectomy Systems (Catheters) Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies thematic reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Thrombectomy Systems (Catheters) Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Thrombectomy Systems (Catheters) Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Thrombectomy Systems (Catheters) Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.